ARCHIVES

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

DCT Board to Study Modifications Of Existing Cooperative Group System

June 13, 1986

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

In Brief: Allegheny Wins NSABP Recompetition; Luri Cancer Center Hosts Princess Diana

June 14, 1996

Working Group To Review NCI Clinical Trials Programs

April 12, 1996

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

In Brief: Gallo Signs Agreement With Univ. of Maryland; Donor Gives $5 Million To San Diego Center

May 26, 1995